Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 12.5B SEK

Wall Street
Price Targets

CALTX Price Targets Summary
Calliditas Therapeutics AB

There are no price targets for CALTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Calliditas Therapeutics AB Competitors:
Price Targets
185750
Chong Kun Dang Pharmaceutical Corp
50% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
24% Upside
SNDL
Sundial Growers Inc
177% Upside
ALM
Almirall SA
20% Upside
ACB
Aurora Cannabis Inc
39% Upside

Revenue
Forecast

Revenue Estimate
Calliditas Therapeutics AB

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

N/A
Past Growth
57%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CALTX's stock price target?
Not Available

CALTX doesn't have any price targets made by Wall Street professionals.

What is Calliditas Therapeutics AB's Revenue forecast?
Projected CAGR
57%

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

Back to Top